[go: up one dir, main page]

AU2001235363A1 - Mibefradil analogues and their use - Google Patents

Mibefradil analogues and their use

Info

Publication number
AU2001235363A1
AU2001235363A1 AU2001235363A AU3536301A AU2001235363A1 AU 2001235363 A1 AU2001235363 A1 AU 2001235363A1 AU 2001235363 A AU2001235363 A AU 2001235363A AU 3536301 A AU3536301 A AU 3536301A AU 2001235363 A1 AU2001235363 A1 AU 2001235363A1
Authority
AU
Australia
Prior art keywords
mibefradil
analogues
mibefradil analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235363A
Inventor
John Bondo Hansen
Ming Li
Tina Moller Tagmose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
University of South Alabama
Original Assignee
Novo Nordisk AS
University of South Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS, University of South Alabama filed Critical Novo Nordisk AS
Publication of AU2001235363A1 publication Critical patent/AU2001235363A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001235363A 2000-02-25 2001-02-23 Mibefradil analogues and their use Abandoned AU2001235363A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200000293 2000-02-25
DKPA200000293 2000-02-25
US18558300P 2000-02-28 2000-02-28
US60185583 2000-02-28
PCT/DK2001/000128 WO2001062740A1 (en) 2000-02-25 2001-02-23 Mibefradil analogues and their use

Publications (1)

Publication Number Publication Date
AU2001235363A1 true AU2001235363A1 (en) 2001-09-03

Family

ID=26068777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235363A Abandoned AU2001235363A1 (en) 2000-02-25 2001-02-23 Mibefradil analogues and their use

Country Status (3)

Country Link
US (1) US20010049447A1 (en)
AU (1) AU2001235363A1 (en)
WO (1) WO2001062740A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1542683B1 (en) * 2002-09-12 2013-01-09 Diakron Pharmaceuticals, Inc. Calcium channel blockers
US20060003985A1 (en) * 2002-10-17 2006-01-05 Renger John J Enhancement of sleep with t-type calcium channel antagonists
EP1730190A4 (en) * 2004-02-11 2008-07-23 Univ Virginia INHIBITION OF CAV3 ISOFORMS AND SPLICE VARIANTS $ G (D) 25B FOR CANCER DIAGNOSIS AND TREATMENT
AU2011203315B8 (en) * 2004-02-11 2012-02-16 University Of Virginia Patent Foundation Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer
JP4927735B2 (en) * 2004-08-20 2012-05-09 ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン T-type calcium channel inhibitor
CN102781316B (en) 2010-03-01 2016-07-06 陶制药有限责任公司 Cancer diagnosis and imaging
CN102614172A (en) * 2012-04-18 2012-08-01 中国人民解放军第三军医大学第二附属医院 Application of T-type calcium channel retardant in drug for treating diabetes
DK3057934T3 (en) * 2013-10-18 2019-07-01 Blanchette Rockefeller Neurosciences Inst Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases
ES2936400T3 (en) 2015-10-22 2023-03-16 Cavion Inc Methods to treat Angelman syndrome
EP3585376A4 (en) 2017-02-15 2020-11-25 Cavion, Inc. Calcium channel inhibitors
CN110770221B (en) 2017-04-26 2023-09-08 卡维昂公司 Methods for improving memory and cognition and for treating memory and cognition disorders
US20220016095A1 (en) 2018-10-03 2022-01-20 Cavion, Inc. Treating essential tremor using (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171349B1 (en) * 1986-11-14 1996-09-16 Hoffmann La Roche Tetrahydronaphthalane derivatives, process for their preparation, medicaments containing the compounds and use of the compounds for the manufacture of medicaments
BR9912021A (en) * 1998-07-10 2001-04-03 Novartis Ag Novartis Sa Movart Treatment method and pharmaceutical composition
WO2000015845A1 (en) * 1998-08-26 2000-03-23 South Alabama Medical Science Foundation T-type calcium channel

Also Published As

Publication number Publication date
US20010049447A1 (en) 2001-12-06
WO2001062740A1 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU3620600A (en) Skin-marking devices and their use
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
AU2003214945A1 (en) Multi-function catheter and use thereof
AU2001249969A1 (en) Inha inhibitors and their use as antibacterials
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2001291072A1 (en) Releasable strap
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
GB0101035D0 (en) Formulation and use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001261750A1 (en) Laminate and its use
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2001235363A1 (en) Mibefradil analogues and their use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU7458201A (en) Laminate and use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses